Skip to main content
. 2018 May 31;61(8):1769–1779. doi: 10.1007/s00125-018-4640-0

Table 1.

Clinical characteristics of participants

Variable TDCOB
Inter99 TCOCT sample Population-based control sample
n Median (interquartile range) n Median (interquartile range) n Median (interquartile range)
Sex (male/female) 2565/2690 306/383 266/409
Age (years) 5255 45.1 (39.9–50.2) 689 11.65 (9.7–13.9) 675 12.54 (10.1–15.2)
Biochemical measures
 HOMA-IR 5063 1.36 (0.9–2.0) 689 4.34 (2.8–6.4) 675 2.23 (1.7–6.4)
 Fasting serum insulin (pmol/l) 5065 34 (23–50) 689 115.00 (77.0–166.5) 675 61.24 (45.5–83.9)
 Fasting plasma glucose (mmol/l) 5251 5.4 (5.1–5.8) 689 5.10 (4.9–5.4) 675 4.97 (4.8–5.2)
 HbA1c (mmol/mol) 5249 39.9 (36.6–43.2) 686 34.00 (33.0–37.0) 636 35.00 (33.0–36.0)
 HbA1c (%) 5249 5.8 (5.5–6.1) 686 5.3 (5.2–5.5) 636 5.4 (5.2–5.4)
 Fasting plasma LDL-cholesterol (mmol/l) 5186 3.42 (2.8–4.1) 680 2.50 (2.1–3.0) 635 2.10 (1.8–2.5)
 Fasting plasma HDL-cholesterol (mmol/l) 5247 1.40 (1.2–1.7) 680 1.20 (1.0–1.4) 635 1.50 (1.3–1.7)
 Fasting plasma total cholesterol (mmol/l) 5246 5.4 (4.8–6.2) 680 4.20 (3.7–4.8) 635 3.90 (3.6–4.5)
 Fasting plasma triacylglycerol (mmol/l) 5251 1.0 (0.8–1.5) 680 0.90 (0.7–1.3) 635 0.60 (0.5–0.9)
Anthropometrics
 BMI (kg/m2) 5253 25.39 (23.1–28.3) NA NA NA NA
 BMI SDS NA NA 689 2.92 (2.5–3.3) 675 0.34 (−0.4–1.0)
 WHR 5252 0.85 (0.8–0.9) 664 0.98 (0.9–1.0) 672 0.83 (0.8–0.9)
BP
 Systolic BP (mmHg) 5254 130 (120–140) NA NA NA NA
 Diastolic BP (mmHg) 5253 80 (75–90) NA NA NA NA
 Systolic BP SDS NA NA 660 1.55 (0.8–2.6) 642 1.57 (0.8–2.6)
 Diastolic BP SDS NA NA 660 0.59 (0.1–1.2) 642 0.42 (−0.1–0.9)
DXA
 Fat mass, total (%) NA NA 391 43.96 (40.4–47.6) 44 25.26 (22.2–31.5)
 Fat mass, torso (%) NA NA 391 45.18 (40.5–49.9) 44 20.27 (16.9–28.5)
 Fat mass, legs (%) NA NA 391 45.63 (42.3–48.8) 44 31.00 (27.5–36.6)
 Fat mass, arms (%) NA NA 391 46.02 (42.4–50.0) 44 31.76 (24.9–36.4)